PDL BioPharma, Inc. (PDLI) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Net income per diluted share (in dollars per share): 0.08
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Net income per diluted share (in dollars per share): 0.08
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q4 EPS of $0.24, in-line with the analyst estimate of $0.24. Revenue for the quarter came in at $72.81 million versus the consensus estimate of $72.85 million.
For earnings history and earnings-related data on PDL BioPharma, Inc. (PDLI) click here.
For earnings history and earnings-related data on PDL BioPharma, Inc. (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor
- ScanSource (SCSC) Tops Q4 EPS by 32c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
